Gentherm(US:THRM)2026-02-19 14:02Financial Data and Key Metrics Changes - Gentherm reported record revenue of $1.5 billion for 2025, an increase of 2.9% compared to the prior year, or 1.8% when excluding foreign currency translation [13] - Adjusted EBITDA for 2025 was $175 million, representing 11%-11.7% of sales, down from 12.6% the previous year due to higher material costs and expenses related to footprint realignment [14] - Operating cash flow increased by 7% to $117 million, despite building inventory throughout the year [14][15] Business Line Data and Key Metrics Changes - Automotive Climate & Comfort solutions revenue increased by 5.8% excluding foreign exchange, while other automotive products saw a decline of $28 million due to planned exits [13] - The company generated a commercial funnel totaling over $300 million in lifetime revenue from markets outside of light vehicles, indicating strong growth potential in adjacent markets [8] Market Data and Key Metrics Changes - Fourth quarter Climate & Comfort solutions revenue outgrew light vehicle production by 820 basis points, demonstrating strong global performance [14] - The company expects light vehicle production in key markets to decrease approximately 1% for 2026, positioning Gentherm to grow above market by mid-single digits [16] Company Strategy and Development Direction - Gentherm is focused on scaling its core technologies beyond automotive, with a strategic combination with Modine's Performance Technologies expected to close by the end of the year, creating a $2.6 billion market leader [7][21] - The company aims to drive growth through both organic and inorganic opportunities, with a focus on adjacent markets such as medical and home and office [8][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the growth trajectory, emphasizing that 2025 financial results do not reflect the company's potential, with expectations for mid-single-digit growth over market in 2026 [5][11] - The company anticipates that the combination with Modine will unlock significant value creation opportunities and accelerate growth in new markets [22][24] Other Important Information - Gentherm's FDA 510(k) submission for the Thermafix system is expected to generate revenue later this year, contributing to the goal of doubling the medical business by 2030 [10][55] - The company is focused on operational rigor and cash flow generation, with an adjusted free cash flow estimate of $80 million-$100 million for 2026 [18] Q&A Session Summary Question: Adjacent end markets and revenue expectations - Management confirmed they will continue to lean into adjacent markets, expecting home and office to contribute $50 million to $100 million in revenue by 2028, with medical products anticipated to double the medical business by 2030 [32][33] Question: Footprint realignment and EBITDA expectations for 2027 - Management stated that the timing for footprint transitions remains on track for completion in 2026, with benefits expected to flow through in 2027, leading to a potential step function change in margins [36][37] Question: Confidence in 2027 revenue guidance - Management expressed confidence in the 2027 revenue number due to strong launch activity in core automotive and traction in adjacent markets [44]